XML Feed for RxPG News   Add RxPG News Headlines to My Yahoo!   Javascript Syndication for RxPG News

Research Health World General
 
  Home
 
 Latest Research
 Cancer
 Psychiatry
 Genetics
 Surgery
 Aging
 Ophthalmology
 Gynaecology
 Neurosciences
 Pharmacology
 Cardiology
 Obstetrics
 Infectious Diseases
 Respiratory Medicine
 Pathology
 Endocrinology
 Immunology
 Nephrology
 Gastroenterology
  IBS
  Liver
   Hepatitis
  GERD
  Constipation
 Biotechnology
 Radiology
 Dermatology
 Microbiology
 Haematology
 Dental
 ENT
 Environment
 Embryology
 Orthopedics
 Metabolism
 Anaethesia
 Paediatrics
 Public Health
 Urology
 Musculoskeletal
 Clinical Trials
 Physiology
 Biochemistry
 Cytology
 Traumatology
 Rheumatology
 
 Medical News
 Health
 Opinion
 Healthcare
 Professionals
 Launch
 Awards & Prizes
 
 Careers
 Medical
 Nursing
 Dental
 
 Special Topics
 Euthanasia
 Ethics
 Evolution
 Odd Medical News
 Feature
 
 World News
 Tsunami
 Epidemics
 Climate
 Business
 
 India
Search

Last Updated: Nov 18, 2006 - 12:32:53 PM

Liver Channel
subscribe to Liver newsletter

Latest Research : Gastroenterology : Liver

   DISCUSS   |   EMAIL   |   PRINT
Inhibiting NF kappa B protects against Liver Injury
Mar 18, 2005 - 11:06:00 PM, Reviewed by: Dr.

The researchers found that inhibiting NF kappa B protects against liver injury by decreasing expression of inflammatory proteins and may be a therapeutic target in liver disease.

 
Liver damage after organ transplantation or hemorrhagic shock is due to a type of injury known as ischemia/reperfusion, occurring when blood flow is temporarily stopped and, upon restoration, leads to massive inflammation and death of liver cells.

Studies have shown that a protein called NF kappa B plays a role in this type of injury, but its precise function is unclear. In a study appearing online on March 17, in advance of the April 1 print edition of the Journal of Clinical Investigation, Christian Trautwein and colleagues from Hannover Medical School interfere with NF kappa B function in liver cells to examine its role in liver injury.

The researchers found that inhibiting NF kappa B protects against liver injury by decreasing expression of inflammatory proteins and may be a therapeutic target in liver disease.
 

- TITLE: Deletion of IKK2 in hepatocytes does not sensitize these cells to TNF-induced apoptosis, but protects from ischemia/reperfusion-injury; April 1 print edition of the Journal of Clinical Investigation
 

PDF of this article

 
Subscribe to Liver Newsletter
E-mail Address:

 

AUTHOR CONTACT:
Christian Trautwein
Hannover Medical School, Hannover, Germany
Phone: 49-511-532-6620; Fax: 49-511-532-5692; E-mail: [email protected]


Related Liver News

MR Elastography may help in early diagnosis of liver fibrosis
Why does prolonged IV feeding damage the liver?
Coffee may reduce risk of alcoholic cirrhosis
Chronic hepatitis in pediatric liver transplant patients
Nanoparticles may pose threat to hepatocytes
Vaccinating Infants of Hepatitis B Mothers Prevents Infection - Systematic Review
Need for treatment modification in older hepatitis C patients
Obese mice are more susceptible to liver abnormalities
TWEAK Induces Liver Progenitor Cell Proliferation
Therapy may not be necessary for asymptomatic autoimmune hepatitis


For any corrections of factual information, to contact the editors or to send any medical news or health news press releases, use feedback form

Top of Page

 

© Copyright 2004 onwards by RxPG Medical Solutions Private Limited
Contact Us